Risk of Severe COVID-19 in Non-Adherent OSA Patients
Status PubMed-not-MEDLINE Jazyk angličtina Země Nový Zéland Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
36387050
PubMed Central
PMC9657257
DOI
10.2147/ppa.s387657
PII: 387657
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, CPAP adherence, OSA, treatment with CPAP, vaccination,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Patients with obstructive sleep apnoea (OSA) are at increased risk of severe course of COVID-19. Vaccination remains to be the most effective prevention of complicated courses of infection. The best contemporary conservative treatment of OSA is continuous positive airway pressure (CPAP) therapy. PURPOSE: To compare vaccination acceptance and outcomes of COVID-19 infection between OSA patients adhering to the CPAP therapy and those who rejected CPAP and surgical therapy. PATIENTS AND METHODS: Subjects were divided into two groups: group A (N = 167) were individuals with sufficient CPAP adherence (more than 4 hours per night on average) over the last 10 years. Group B (N = 106) were individuals who did not use the CPAP therapy at all and had no indications to surgical therapy. RESULTS: Three patients in group B died, and one had a severe course of COVID-19. None of the patients in group A died or experienced a severe course of COVID-19. Group A had a significantly higher proportion of males (77.8% compared to 66% in group B) and all parameters of OSA severity. The vaccination status was similar among both groups, with a complete triple dose vaccination rate of 69.5% and 67.9% in groups A and B, respectively. CONCLUSION: The results show that the patients with OSA adherent to CPAP therapy were less likely to experience a severe course of COVID-19 or death than the OSA patients non-compliant with therapy, despite the former group having more severe OSA. This result underlines the importance of adherence to CPAP therapy in OSA.
Department of Biophysics Palacky University Olomouc Olomouc Czech Republic
Institute for Postgraduate Education in Health Care Prague Czech Republic
Zobrazit více v PubMed
Ruan H, Xun P, Cai W, et al. Habitual sleep duration and risk of childhood obesity: systematic review and dose-response meta-analysis of prospective cohort studies. PubMed PMC
Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. PubMed DOI
Lombardi C, Tobaldini E, Montano N, Losurdo A, Parati G. Obstructive Sleep Apnea Syndrome (OSAS) and cardiovascular system. PubMed DOI
Maas MB, Kim M, Malkani RG, et al. Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. PubMed DOI PMC
Mashaqi S, Lee-Iannotti J, Rangan P, et al. Obstructive sleep apnea and COVID-19 clinical outcomes during hospitalization: a cohort study. PubMed DOI PMC
Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: a systematic review and meta-analysis of acceptability and its predictors. PubMed DOI PMC
Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. PubMed DOI PMC
Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. PubMed
Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. PubMed DOI
Chami HA, Resnick HE, Quan SF, Gottlieb DJ. Association of incident cardiovascular disease with progression of sleep-disordered breathing. PubMed DOI PMC
Martinez D, Klein C, Rahmeier L, et al. Sleep apnea is a stronger predictor of coronary heart disease than traditional risk factors. PubMed DOI
Jaffe LM, Kjekshus J, Gottlieb SS. Importance and management of chronic sleep apnoea in cardiology. PubMed DOI
Sova M, Sovova E, Hobzova M, Zapletalova J, Kamasova M, Kolek V. The effect of continuous positive airway pressure therapy on the prevalence of masked hypertension in obstructive sleep apnea patients. PubMed DOI
Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. PubMed DOI
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep disordered breathing and hypertension. PubMed DOI
Han Q, Yeung SC, Ip MS, Mak JC. Cellular mechanisms in intermittent hypoxia-induced cardiac damage in vivo. PubMed DOI
Batool-Anwar S, Goodwin JL, Kushida CA, et al. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). PubMed DOI PMC
Genzor S, Prasko J, Vanek J, Asswad AG, Nadjarpour S, Sova M. Adherence of obstructive sleep apnoea syndrome patients to positive airway pressure therapy - 10-year follow-up. PubMed DOI
Watach AJ, Hwang D, Sawyer AM. Personalized and patient-centered strategies to improve positive airway pressure adherence in patients with obstructive sleep apnea. PubMed DOI PMC
Baratta F, Pastori D, Bucci T, et al. Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome. PubMed DOI
Chai-Coetzer CL, Luo YM, Antic NA, et al. Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study. PubMed DOI PMC
Lao M, Cheng Y, Gao X, Ou Q. The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial. PubMed DOI PMC
Demirovic S, Lusic Kalcina L, Pavlinac Dodig I, et al. The COVID-19 lockdown and CPAP adherence: the more vulnerable ones less likely to improve adherence? PubMed DOI PMC
Attias D, Pepin JL, Pathak A. Impact of COVID-19 lockdown on adherence to continuous positive airway pressure by obstructive sleep apnoea patients. PubMed DOI PMC
AASM. American Academy of Sleep Medicine, diagnostic and scoring manual, version 2.6.; 2020.
Van Ryswyk E, Anderson CS, Antic NA, et al. Predictors of long-term adherence to continuous positive airway pressure in patients with obstructive sleep apnea and cardiovascular disease. PubMed DOI
Dzierzewski JM, Wallace DM, Wohlgemuth WK. Adherence to continuous positive airway pressure in existing users: self-efficacy enhances the association between continuous positive airway pressure and adherence. PubMed DOI PMC
Gagnadoux F, Le Vaillant M, Goupil F, et al. Influence of marital status and employment status on long-term adherence with continuous positive airway pressure in sleep apnea patients. PubMed DOI PMC
Campbell A, Neill A, Lory R. Ethnicity and socioeconomic status predict initial continuous positive airway pressure compliance in New Zealand adults with obstructive sleep apnoea. PubMed DOI
Inoue A, Chiba S, Matsuura K, Osafune H, Capasso R, Wada K. Nasal function and CPAP compliance. PubMed DOI
Papadogiannis G, Bouloukaki I, Mermigkis C, et al. Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment. PubMed DOI PMC
Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. PubMed DOI PMC
Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. PubMed DOI
Pack AI, Magalang UJ, Singh B, Kuna ST, Keenan BT, Maislin G. Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias. PubMed DOI PMC